Next |
home / stock / lpcn / lpcn message board
Subject | By | Source | When |
---|---|---|---|
$LPCN short squeeze signal | RunninRobert | investorshub | 05/12/2023 7:26:37 AM |
Bottom was in on the eighth | Triple nickle | investorshub | 05/11/2023 4:27:09 PM |
Added | Triple nickle | investorshub | 05/11/2023 4:25:38 PM |
Time for this to show some returns | gi197845 | investorshub | 05/11/2023 4:04:56 AM |
$LPCN Found an interesting article | gi197845 | investorshub | 05/10/2023 6:49:32 PM |
The now last up | gi197845 | investorshub | 05/08/2023 5:31:32 PM |
$LPCN Time for this to show some returns | gi197845 | investorshub | 05/08/2023 6:00:54 AM |
$LPCN here we go bulls news is here | Vance | investorshub | 05/07/2023 6:08:29 PM |
$LPCN The gaining | BesaoT35 | investorshub | 05/07/2023 4:27:08 AM |
$LPCN MomentumIts gaining | gi197845 | investorshub | 05/06/2023 10:16:15 PM |
$LPCN just the news we needed | gi197845 | investorshub | 05/06/2023 4:41:30 PM |
$LPCN The gaining | gi197845 | investorshub | 05/05/2023 10:34:06 PM |
$LPCN bulls and bears | gi197845 | investorshub | 05/05/2023 1:09:47 PM |
Price trading | gi197845 | investorshub | 05/04/2023 7:06:18 PM |
$LPCN got some short data | Vance | investorshub | 05/04/2023 10:57:37 AM |
short squeeze signal | Vance | investorshub | 05/03/2023 11:32:28 AM |
$LPCN Price now | BesaoT35 | investorshub | 05/01/2023 8:44:43 PM |
$LPCN Price trading | Vance | investorshub | 05/01/2023 5:24:58 PM |
best news of the day | Pyramid2 | investorshub | 04/30/2023 9:41:01 PM |
$LPCN MomentumIts now | gi197845 | investorshub | 04/30/2023 4:50:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 PR Newswire Pivotal study design aligned with FDA on streamlined pathway to NDA submission goal in 2024 Topline results anticipated late in 2Q 2024 SALT LAKE CITY ...
2024-04-11 09:01:37 ET DENVER, Colo., Apr 11, 2024 ( 247marketnews.com )- Lipocine Inc. (NASDAQ: LPCN ) results from a Phase 2 clinical trial including LPCN 2401, an oral proprietary combination of anabolic androgen receptor agonist and α-tocopherol, an antioxidant, which sho...
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity PR Newswire LPCN 2401 treatment resulted in statistically significant body composition improvement in men Increased lean mass (LM) by 4.4% and decreased fa...